IPO Trending
ONYXSME / NSEListed

Onyx Biotec Limited

Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company focused on producing sterile water for injections and offering contract manufacturing services. It operates two facilities in Solan, Himachal Pradesh, where Unit I makes up to 6.38 lakh units of sterile water injections daily, and Unit II manufactures 40,000 units of dry powder injections and 26,667 units of dry syrup per day. The company caters to both domestic and international markets and serves over 100 clients, including well-known names like Hetero Healthcare, Mankind Pharma, Sun Pharma, and Reliance Life Sciences. Onyx Biotec is ISO 9001:2015 and ISO 14001:2015 certified and employed 175 people as of July 31, 2024.

₹58 - ₹61198.68x sub
Listed Price54.05
Listing Gain-11.39%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (May 2024)1054.1 Cr
Growth-76.6%
Revenue Trend (₹ in Crores)
0.02.1k4.1k6.2kMar 2022Mar 2023Mar 2024May 2024
PeriodRev (Cr)PAT (Cr)AssetsDebt
May 20241,054.1130.77,476.53,156.1
Mar 20245,387.4303.17,413.53,078.0
Mar 20233,961.6184.45,872.32,922.8
Mar 20224,498.0335.23,683.81,224.3
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
May-240.984.99%3.71%26.8114.1
Mar-242.5412.19%10.58%0.000.00
Mar-231.5610.13%6.29%0.000.00